Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective interventional

Detection Principle
NucleicAcid-PCR based
ORF1b, E (QIAstat); E, RdRP (PCR)
Testing Method Category
PCR_KIT & other
Testing Method
kit (QIAstat-Dx), and laboratory PCR at POC
Testing Method - Additional Info
QIAstat-Dx Respiratory SARS-CoV-2 Panel & PCR at POC
Reported Performance
Sensitivity: 99.4% (QIAstat), 85.9% (PCR); Specificity: 98.6% (QIAstat), 99% (PCR); Accuracy: 98.9% (QIAstat), 94% (PCR)
Sample Size
499 patients & 55 controls

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements